Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Bitmine CEO Tom Lee Says the Cryptocurrency Market is at the Beginning of a Super Cycle! Here Are the Details

Bitmine CEO Tom Lee Says the Cryptocurrency Market is at the Beginning of a Super Cycle! Here Are the Details

BitcoinSistemiBitcoinSistemi2026/10/07 10:18

Bitmine CEO Tom Lee argued that the cryptocurrency market is at the beginning of a long-term and comprehensive growth period. Lee predicted that a large portion of the assets managed in the traditional financial sector will be tokenized within the next 10 years.

Speaking at the Token2049 event, Lee described the current period as the beginning of a “super cycle” for crypto assets. According to Lee, the increasing integration of blockchain technology into the traditional financial system will play a significant role in the growth of the crypto ecosystem in the coming years.

Lee specifically highlighted developments in the field of tokenization. He stated that most assets managed in the traditional financial sector could be converted into blockchain-based tokens within the next 10 years, adding that this transformation could create significant changes in the infrastructure of financial markets.

Tokenization stands out as a framework that makes it possible to represent stocks, bonds, and other financial assets on the blockchain through digital tokens. According to Lee’s assessment, the adoption of this technology could enable greater integration of crypto infrastructure with traditional finance.

Lee also pointed out that major financial institutions such as BlackRock, JPMorgan, and Robinhood are developing tokenization-related infrastructure on Ethereum (ETH). He argued that these efforts could strengthen Ethereum’s role in the digitalization of financial assets.

Fundstrat’s co-founder stated that institutional finance organizations’ adoption of blockchain infrastructure is crucial for the long-term development of the cryptocurrency market.

Lee’s “super cycle” assessment reflects his personal market view for the future, while the pace of tokenization over the next 10 years will depend on regulatory developments, institutional adoption, and the advancement of technological infrastructure.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals

October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)

路透社•2026/10/09 04:26
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals

Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low

UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.

智通财经•2026/10/09 03:53